Rivaroxaban Approved by FDA to Prevent Strokes in AF Patients
The FDA recently approved another oral anticoagulant medication to help prevent strokes in patients with atrial fibrillation (AF). On November 4, the FDA announced its approval of rivaroxaban (Xarelto) for...
Study: AF Patients Experience Recurrence of Renal Dysfunction After Cardioversion
A new study, which was approved by the ethics committee of the University of Freiburg, has found that impaired renal function can be linked to patients with atrial fibrillation experiencing...
Canadians Question Study Results Claiming Pradaxa Helps AF Patients Prevent Clots and Control Heart Rhythms
Canadian researchers from the University of British Columbia are questioning the clinical trial results which found that the drug Pradaxa was safe and effective at helping atrial fibrillation (AF) patients...
AtriCure Ablation System for AF Approved by FDA
The FDA’s Circulatory System Devices advisory panel has narrowly approved the AtriCure Ablation System for AF. The panel gave it a “cautious” approval, signaling that some panel members still have...
Sanofi Restructuring as it Battles Looming Patent Expiries
This morning, drug maker Sanofi (makers of the controversial drug heart drug Multaq) has posted its financial information for the third quarter. The company is showing that its net profit...